U-M launches effort to collect blood samples from COVID-19 survivors & patients for research

Donations will aid scientists’ search for answers about the coronavirus and its effects

Author | Kara Gavin

The key to defeating COVID-19 might be floating in the blood of the tens of thousands of Michiganders who have recovered from the disease, and the thousands more who are still feeling its effects.

Now, they can get their revenge on the virus that made them sick, by donating a few teaspoons of their blood to the University of Michigan.

Those donations, shared among dozens of scientific teams, will fuel new COVID-19 research projects at U-M and beyond. U-M scientists and their colleagues are working to understand the coronavirus and its effects, and develop new ways to prevent and treat the disease it causes.

People who have tested positive for COVID-19 can express interest in donating blood samples and sharing their health information in a secure way for scientists to use in their research. More information is available at http://michmed.org/lAapv or via [email protected].

Already, 800 COVID-19 patients cared for at U-M’s academic medical center, Michigan Medicine, have donated more than 17,000 samples to the effort. Now, it is open to participants who are not Michigan Medicine patients. 

A library for COVID-19 scientists

All donated samples will become part of the U-M COVID-19 Biorepository. This “library” of samples, kept frozen, allows researchers to take tiny amounts of each donor’s blood cells or plasma back to their labs for analysis. An advanced information system keeps the identities of the donors, and information about their health, secure.

By studying hundreds of samples, scientists can learn what molecules are most often found in the blood of people with active or past COVID-19. They’re looking for signs of the immune system’s response to the virus, such as antibodies, cytokines and more.

Researchers can also use advanced genetic analysis to see what genes in patients’ cells were most active at the time samples were taken. This could help uncover how tiny variations in DNA might play a role in how ill someone gets when infected.

The data generated by each team’s analysis can be shared with other scientists, so that one person’s samples can fuel many different projects and answer many different questions.

People who give a COVID-19 blood sample to U-M can also give permission for their information to be shared outside U-M, with companies developing diagnostic tests, drugs and more.

The COVID-19 library is part of the larger U-M Central Biorepository, which has more than half a million samples from more than 108,000 people. This includes more than 87,000 people who have had surgery at U-M and are part of the Michigan Genomics Initiative run by U-M Precision Health. Some of those samples will provide valuable comparisons for the COVID-19 samples.

In addition to the COVID-19 Biorepository project, U-M researchers need participants for a wide range of other studies – including people who have not yet had COVID-19, and people who have had symptoms but have not had a positive result on either a test for active infection or antibodies. More information: http://michmed.org/39j1B

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories 10 year old boy leaning against tree and posing with his mom and sisters outside
Health Lab
Family travels over 1,000 miles for son’s heart transplant
Family travels over 1,000 miles for son's heart transplant and ongoing heart care
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Period Poverty and the Need to Make Menstruation Products Easier to Access
A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.
Health care provider with stethoscope holds patient's hand
Health Lab
Opinion: Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
An end-of-life care specialist discusses the shortfalls of hospice care coverage for people with dementia, using the experience of former President Jimmy Carter and former First Lady Rosalynn Carter as examples.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.
Illustration of a microscope
Health Lab
Researchers uncover distinct molecular subgroups of kidney disease for personalized treatment
Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.